OPHTHOTECH CORP's ticker is OPHT and the CUSIP is 683745103. A total of 94 filers reported holding OPHTHOTECH CORP in Q3 2014. The put-call ratio across all filers is 0.92 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $13,935,000 | -39.2% | 310,554 | -47.3% | 1.50% | -44.7% |
| Q3 2014 | $22,927,000 | +2.6% | 588,941 | +11.6% | 2.71% | +20.0% |
| Q2 2014 | $22,337,000 | -64.0% | 527,941 | -69.6% | 2.26% | -49.2% |
| Q1 2014 | $61,998,000 | +19.7% | 1,737,856 | +8.6% | 4.45% | -26.3% |
| Q4 2013 | $51,775,000 | – | 1,600,455 | – | 6.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JHL Capital Group LLC | 3,265,000 | $166,613,000 | 20.59% |
| Novo Holdings A/S | 3,610,487 | $184,243,000 | 19.34% |
| Green Owl Capital Management, LLC | 847 | $834,000 | 5.16% |
| Ghost Tree Capital, LLC | 215,000 | $10,971,000 | 3.17% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 16,110 | $822,000 | 2.76% |
| IMA Wealth, Inc. | 57,131 | $2,867,000 | 1.80% |
| Slate Path Capital LP | 430,000 | $21,943,000 | 1.72% |
| Signpost Capital Advisors, LP | 50,587 | $2,581,000 | 1.36% |
| Orbimed Advisors | 2,148,100 | $109,618,000 | 1.14% |
| PURA VIDA INVESTMENTS, LLC | 52,500 | $2,679,000 | 1.14% |